FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099843 [Registered on: 26/12/2025] Trial Registered Prospectively
Last Modified On: 25/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Mean magnesium levels in children aged 2 months to 3 years with recurrent wheeze and non wheezers and correlation with number of episodes and respiratory distress severity 
Scientific Title of Study   Serum magnesium levels and recurrent wheeze in children between 2 months to 3 years of age 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shaily Singh 
Designation  Post Graduate Resident 
Affiliation  Maulana Azad Medical College 
Address  Ward 17 Department of Pediatrics Maulana Azad Medical College 2, Bahadurshah Zafar Marg, New Delhi - 02

New Delhi
DELHI
110002
India 
Phone  8272876474  
Fax    
Email  emailshailysingh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Deepak Kumar 
Designation  Professor 
Affiliation  Maulana Azad Medical College 
Address  Department of Pediatrics Maulana Azad Medical College 2, Bahadurshah Zafar Marg, New Delhi - 02

New Delhi
DELHI
110002
India 
Phone  9211377848  
Fax    
Email  deepakk70@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Deepak Kumar 
Designation  Professor 
Affiliation  Maulana Azad Medical College 
Address  Department of Pediatrics Maulana Azad Medical College 2, Bahadurshah Zafar Marg, New Delhi - 02

New Delhi
DELHI
110002
India 
Phone  9211377848  
Fax    
Email  deepakk70@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College and Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, India 110002 
 
Primary Sponsor  
Name  Maulana Azad Medical College, New Delhi 
Address  2, Bahadurshah Zafar Marg, New Delhi - 02 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shaily Singh  Maulana Azad Medical College and associated Lok Nayak Hospital  Ward 14, Pediatric Emergency, Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital New Delhi DELHI
New Delhi
DELHI 
8272876474

emailshailysingh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Maulana Azad Medical College and associated Hospitals (Lok Nayak, GB Pant Institute Post Graduate Medical Education and Research Hospital, Guru Nanak Eye Centre, New Delhi)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J22||Unspecified acute lower respiratory infection,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  2.00 Month(s)
Age To  3.00 Year(s)
Gender  Both 
Details  Children between 2 months to 3 years of age presenting with recurrent wheeze ( more than 2 episodes since birth) 
 
ExclusionCriteria 
Details  1) Children with known causes of recurrent wheeze (eg congenital heart disease, chronic lung disease, tuberculosis, GERD, Immunodeficiency, and neurological disorders)
2) Children who have received nutritional supplements containing magnesium in the last 7 months. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Mean difference in serum magnesium levels in children with recurrent wheeze and those without recurrent wheeze aged 2 months to 3 years.  At baseline 
 
Secondary Outcome  
Outcome  TimePoints 
1) Correlation between serum magnesium levels & the frequency of episodes
2) Association of respiratory distress severity criteria with magnesium levels in children aged 2 months to 3 years with recurrent wheeze. 
At baseline 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   08/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Recurrent wheezing is a prevalent respiratory problem that impacts a significant proportion of children especially younger than 3 years due to bronchospasm, mucosal edema, and accumulation of excessive secretions causing a greater obstructive effect on their smaller, more compliant airways. Magnesium has been shown to relax bronchial smooth muscle in vitro, however the correlation between serum magnesium levels and the severity of wheezing remains controversial. Serum magnesium levels can have implications in prevention and management of recurrent wheeze in this vulnerable population.    
Close